Active · per the CBE, 17 November 2026

OPERO

BE0760816827

Rechtspersoon Private limited company 1 establishment

OPERO is a research organisation in Grimbergen. Private Limited, started on 5 January 2021, 1 establishment.

Bintjeshof 1, 1851 Grimbergen

Behind the company: Kristof Vandekerckhove.

Active for

5 year, 10 months

Financials

Financial year 2025

OPERO from Grimbergen, company number BE0760816827, closed financial year 2025 with a result of € 130,586 after tax. For that financial year OPERO recorded a gross margin of € 168,579 and equity of € 5,049. Compared with financial year 2024, the result moved from € 166,233 to € 130,586. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 12, 2026.

What it is worth Healthy

€ 5,049

▼ 47% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 130,586

▼ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 156,608

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 135,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 29,508

▲ € 27,591 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,837

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 176,940 € 146,213 € 216,841 € 168,579 ▼ 22%
Profit after taxes € 136,156 € 113,486 € 166,233 € 130,586 ▼ 21%
Equity € 289,744 € 403,230 € 9,463 € 5,049 ▼ 47%
Total debts € 106,132 € 52,558 € 186,584 € 220,933 ▲ 18%
Cash € 374,756 € 434,441 € 166,006 € 156,608 ▼ 6%
Retained profit € 284,744 € 398,230 € 4,463 € 49 ▼ 99%
Dividend € 0 € 0 € 560,000 € 135,000 ▼ 76%
Balance sheet total € 395,876 € 455,788 € 196,046 € 225,981 ▲ 15%

By gross margin, OPERO ranks 13th of 48 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in Flemish Brabant that publish figures (fiscal year 2025).

Key figures of OPERO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OPERO?

What happened at OPERO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 130,586 (▼ 21% vs 2024). Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Grimbergen. KBO

In short

From € 136,156 profit in 2022 to € 130,586 profit in 2025.

Paid € 159,131 in corporate taxes since 2022.

Best year ever: 2024, with € 166,233 profit.

Paid out € 695,000 in dividends to the owners in total.

Management

Kristof Vandekerckhove
OPERO

Behind OPERO is Kristof Vandekerckhove.

Directors

According to the 2025 annual accounts

Kristof Vandekerckhove

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Bintjeshof 1

1851 Grimbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Flemish Brabant

Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 72 active companies in Flemish Brabant, largest first.

Swedish Orphan Biovitrum (Belgium)

€ 8.3 million revenue · 2025 · Zaventem

OGEDA

€ 5.9 million gross margin · 2025 · Vilvoorde

BIOMEDICAL SYSTEMS

€ 3.7 million gross margin · 2025 · Leuven

ALIGOS BELGIUM

€ 3.2 million gross margin · 2025 · Leuven

K5 Therapeutics

€ 2.6 million gross margin · 2025 · Leuven

ClinChoice Belgium

€ 1.8 million gross margin · 2025 · Kraainem

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • VANDEKERCKHOVE Kristof Cyriel Paul(oprichter) 100%

Details

Company number
0760.816.827
VAT number
BE 0760.816.827
Registered office
Bintjeshof 1, 1851 Grimbergen
Names & denominations
OPERO
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
5 January 2021
Peppol
Active · Active since 26 Jul 2024
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Organisatie van congressen en beurzen

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige vormen van onderwijs

Overige zakelijke dienstverlening, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What does OPERO do?
OPERO is a research organisation in Grimbergen. Private Limited, started on 5 January 2021, 1 establishment.
What is the address of OPERO?
The registered office of OPERO is located at Bintjeshof 1, 1851 Grimbergen.
Is OPERO still active?
Yes. According to the CBE (17 November 2026) OPERO is active, legal situation “Normale toestand”, started on 5 January 2021.
Is OPERO registered on Peppol?
Yes, OPERO is registered on the Peppol network with ID 0208:0760816827.
What is the enterprise number of OPERO?
The enterprise number of OPERO is BE0760816827.
When was OPERO founded?
OPERO was founded on 5 January 2021.